Fundz

Plexision raised $365,000 to enhance transplant outcome care using AI. The funding from the Richard King Mellon Foundation will accelerate AI integration in cell-based blood tests.

PRIVATEJul 24, 2025

Amount Raised

$365,000

Round Type

Funding Round

PittsburghBiotechnologyHealth CareArtificial Intelligence

Investors

Richard King Mellon Foundation

Description

Plexision, a biotechnology company, announced a $365,000 investment from the Richard King Mellon Foundation. The funds will be used to accelerate the integration of artificial intelligence and machine learning in their blood tests for transplant outcomes. This aims to improve predictive accuracy for complex transplant scenarios. Their innovative approach will be showcased at the World Transplant Congress in August 2025.

Quick answer

Plexision raised $365,000 in a Funding Round round, dated July 24, 2025. Investors: Richard King Mellon Foundation. Plexision is based in Pittsburgh, Pennsylvania, United States.

How much did Plexision raise?
Plexision raised $365,000 in a Funding Round round on July 24, 2025.
Who invested in Plexision?
Richard King Mellon Foundation is named as investors in this round.
What does Plexision do?
Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, and immunological disorders.
Where is Plexision based and how big is it?
Plexision is based in Pittsburgh, Pennsylvania, United States. Fundz records about 8 employees.
Who are the decision-makers at Plexision?
Fundz holds 2 contacts at Plexision. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Plexision that raised within 45 days of this round, from Fundz verified event records.

  • Joint Ai raised $315K (Funding Round) on September 4, 2025.
  • Seluna raised $874K (Funding Round) on August 28, 2025.
  • Method AI raised $20M (Series A) on August 21, 2025.
  • Citizen Health raised $30M (Series A) on August 15, 2025.
  • pRxEngage raised an undisclosed amount (Seed) on July 29, 2025.
  • Moberg Analytics raised an undisclosed amount (Seed) on July 29, 2025.

Who to call at Plexision, and when

A new round usually means Plexision is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Plexision raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Plexision, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Plexision. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Plexision

Location

Pittsburgh, Pennsylvania, United States

About

Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, and immunological disorders. Plexision's first patented product, the PleximmuneTM assay, predicts the risk of transplant rejection. The test is based on patent-pending technology to measure antigen-specific white blood cells. Testing services for transplant recipients and drug developers are provided at Plexision’s CLIA-certified, central laboratory in Pittsburgh. Plexision currently offers cell-based testing for personalized assessment of rejection risk after solid organ transplantation The Pleximmune blood test is the first such test offered for children with liver or intestine transplantation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Plexision raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Plexision's next move

See what Strategic adds

Plexision raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.